1. Home
  2. SPCB vs LSTA Comparison

SPCB vs LSTA Comparison

Compare SPCB & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.90

Market Cap

43.8M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCB
LSTA
Founded
1988
1980
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
20.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SPCB
LSTA
Price
$8.90
$2.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$18.00
$23.50
AVG Volume (30 Days)
92.5K
23.8K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.84
N/A
Revenue
$26,739,000.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
N/A
P/E Ratio
$11.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.14
$1.81
52 Week High
$18.95
$4.20

Technical Indicators

Market Signals
Indicator
SPCB
LSTA
Relative Strength Index (RSI) 43.64 47.29
Support Level $8.64 $1.97
Resistance Level $9.92 $2.15
Average True Range (ATR) 0.49 0.13
MACD 0.04 0.02
Stochastic Oscillator 28.62 62.50

Price Performance

Historical Comparison
SPCB
LSTA

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: